Multicenter Collaborative Study to Optimize Mass Spectrometry Workflows of Clinical Specimens.

Standardized workflows for mass spectrometry (MS) are critical for integrating proteomics into clinical settings. Prior research has established the need for consistent protocols across diverse sample types and instruments. However, a gap remains in harmonizing sample preparation and LC-MS methods across multiple laboratories. Existing studies focus on individual techniques rather than collaborative benchmarking. This gap motivated a multicenter effort to identify commonalities and optimize workflows. The CLINSPECT-M consortium aimed to address this by comparing and refining practices across six labs. Plasma and cerebrospinal fluid (CSF) were selected as clinically relevant matrices. The study aimed to improve reproducibility and data completeness through shared best practices. This approach builds on prior work but introduces a collaborative framework for practical improvements.

The goal of this multicenter study was to evaluate and enhance the consistency of MS workflows for clinical specimens. The specific problem addressed was the lack of standardized protocols across different laboratories. Researchers sought to determine how shared best practices could improve reproducibility and data quality. Plasma and CSF were chosen as sample matrices due to their clinical relevance. The study partners were allowed full freedom in sample preparation and MS measurements. This flexibility enabled a realistic assessment of current practices. The first round provided baseline performance metrics for each lab. The second round aimed to measure improvements after protocol exchange and refinement.

Six laboratories participated in two consecutive rounds of sample analysis. Each lab used its own protocols for plasma and CSF in the first round. After sharing protocols transparently, the labs refined their methods for the second round. Identifications, data completeness, and precision were measured in both rounds. No external standards or fixed protocols were imposed. The study focused on comparing pre- and post-refinement performance. Metrics included reproducibility and the number of identified proteins. The approach allowed for a direct comparison of lab-specific improvements. This method emphasized practical, real-world adjustments rather than theoretical models.

The second measurement round showed improved performance across all six labs. The number of identifications increased in both plasma and CSF samples. Data completeness and precision metrics were enhanced compared to the first round. Reproducibility improved significantly after protocol refinement. These results suggest that shared best practices led to practical improvements. No lab showed a decline in performance after the protocol exchange. The most notable gains were in reproducibility and ID consistency. The study demonstrated the effectiveness of collaborative benchmarking.

The authors propose that transparent protocol sharing among labs improves MS workflow performance. They suggest that collaborative refinement leads to more reproducible and complete data. The study supports the importance of expert-driven exchanges in clinical proteomics. No claims of necessity or essentiality are made beyond the observed improvements. The findings do not propose new drug targets or future directions. The authors emphasize practical benefits of protocol harmonization. They suggest that this approach can be extended to other clinical matrices. The results align with the study's aim of improving current best practices.